Coreg® 12.5 mg Tablets , single dose

DRUG2 trials

Sponsors

Actavis Inc.

Conditions

Healthy

Phase 1

A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Fasting Conditions

CompletedNCT00864435

Actavis Inc.Healthy

Start: 2005-10-31End: 2005-11-30Updated: 2010-08-16

A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Non-fasting Conditions

CompletedNCT00864149

Actavis Inc.Healthy

Start: 2005-10-31End: 2005-11-30Updated: 2010-08-16